Abstract -Aclarubicin (ACLA), which belongs to the antracycline class of antineoplasic agents, has been demonstrated as a differentiating agent of human leukemia, including HL-60 cells. We report here on the incidence of ACLA-induced differentiation on matrix metalloproteinase (MMP) expression and cell invasiveness. The aim of this study was to investigate the involvement of reactive oxygen species (ROS) as mediators of ACLA-induced effects. By using a fluorescent probe, we showed that subtoxic (i.e. differentiating) concentration of ACLA generate reactive oxygen species in HL-60 cells. ACLAdifferentiated cells exhibited an increased proMMP-9 secretion which has been observed by gelatin zymography and immunoassay. Antioxidants were able to inhibit ACLA-induced differentiation and proMMP-9 secretion. Furthermore, RT-PCR showed that ACLA increased MMP-9 and tissue inhibitor of MMP (TIMP-1) expression in a ROS-dependent manner. In addition, the migration and invasion capacities of HL-60 cells were enhanced by ACLA treatment, but only partially reversed by antioxidants. Altogether, these results evidenced ROS as messengers of ACLA-induced differentiation and MMP-9 expression.
INTRODUCTION
Aclarubicin (ACLA) belongs to the anthracycline class of antineoplasic agents widely used in conventional cancer chemotherapy of solid tumor and leukemia (1) . While anthracyclines cytotoxic effects are commonly accepted to be due to DNA-intercalation and interaction with the nuclear enzymes DNA-topoisomerases (2), additional targets have been proposed such as alteration of the mitochondrial function (3) , and production of free radicals (4, 5) . The ability of anthracyclines to produce reactive oxygen species (ROS), in cells or tissues has been demonstrated with high concentration, as commonly used in cytotoxic chemotherapy (4, 5) . Then, oxidative damages consecutive to anthracycline treatment were thought to explain the high cardiotoxicity of these drugs (6) . Besides, when used at subtoxic concentration (nanomolar range) anthracycline, and especially ACLA, are potent differentiation inducers of solid tumor and leukemia (7, 8) . It should be noticed that the subtoxic concentration of ACLA used in differentiation studies was 50-200 times lower than the plasmatic concentration found in patients undergoing classical chemotherapeutic treatment (9) .
The human leukemia cell line HL-60 is derived from the peripheral blood of a 36 year old woman and represent a widely used model of acute myeloid leukemia type 2 (AML-2) (10). When exposed to differentiation inducers such as all-trans-retinoic acid (ATRA) or phorbol esters, HL-60 cells can be committed toward granulocytic or monocytic pathways, respectively (11, 12) . Induction of granulocytic differentiation of HL-60 cells can also be achieved with subtoxic concentration of ACLA, whereas other anthracyclines were inefficient (13, 14) . Cell differentiation was associated with adhesion and migration modifications as recently described in ATRA-treated leukemia cells (15, 16) . Furthermore, several groups have shown that differentiation of HL-60 cells, when induced by either ATRA or phorbol ester, is accompanied with changes in their matrix metalloproteinases (MMPs) expression (17) (18) (19) .
hal-00422906, version 1 -8 Oct 2009
MMPs are a family of zinc-dependent endopeptidases that degrade all of the components of extracellular matrix (20, 21). MMP-2 and MMP-9 (gelatinases A and B), which are secreted as the latent forms proMMP-2 and proMMP-9, are the more frequently found in leukemia cells or cell lines (22). MMPs expression, secretion and activity are highly regulated, particularly by a family of highly specific inhibitor proteins called tissue inhibitors of metalloproteinases (TIMPs) (20, 23). Therefore, secretion of MMP-9 and/or MMP-2 was thought to be involved in the invasive properties of malignant cells (24), including leukemia (25, 26). Nevertheless, biological significance of MMPs and TIMPs expression is complex since TIMPs could also have growth-promoting effects and numerous MMPs as well as other matrix-degrading enzymes could be involved in the invasive process (20-24).
In the present work, we aimed first at evaluating the effect of ACLA on MMP and TIMPs expression, and invasiveness of HL-60 cells. The second aim was to investigate the role of ROS as mediators of ACLA-induced differentiation and increased MMP-9 expression.
The results show that ROS are involved in ACLA-induced differentiation and MMP-9 overexpression, but only partially in ACLA-enhanced invasion.
MATERIALS AND METHODS

Chemicals
Matrigel®, a basement membrane preparation extracted from murine Engelbreth-HolmSwarm tumors, was purchased from BD Biosciences (Le Pont de Claix, France). The C2938 fluorescent probe (6-carboxy-2',7'-dichlorodihydrofluorescein diacetate, di(acetoxymethyl ester)) was from Molecular Probes (Eugene, Oregon). ACLA and the antioxidants Nacetylcysteine (NAC) and pyrrolidine dithiocarbamate (PDTC) were purchased from Sigma
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(L'Isle d'Abeau Chesnes, France), and were prepared as previously described (27) , except NAC which was buffered to pH 7.4 with sodium hydroxide.
Cell culture
The human leukemia HL-60 cell line from the American Type Culture Collection (CCL-240) was maintained in RPMI 1640 medium plus glutamax (Life Technologies, Saint Quentin en Yvelines, France) supplemented with 15% heat-inactivated fetal calf serum (Life Technologies) under standard culture conditions. The presence of serum is required for differentiation induction in classical culture media but interferes with MMPs determination (gelatin zymography and immunoassays). Therefore, for all experiments, serum-free cultures of exponentially growing cells were performed in UltraCULTURE medium (BioWhittaker, Emerainville, France) supplemented with 2 mM L-glutamine, which allow both differentiation and MMP determination (28) . The cell number and viability were determined by the Trypan blue dye-exclusion method.
Differentiation assay
After 3 days of treatment with 25 nM ACLA, and in the presence or absence of antioxidants, the differentiation of HL-60 cells was assessed by nitroblue tetrazolium (NBT) dye reduction as previously described (11) (12) (13) 28) . Cells containing blue-black formazan granules, indicative of the ability of HL-60 cells to generate superoxide anion during a phorbol ester-induced respiratory burst, were scored as differentiation positive. In addition, cytospin of control or ACLA-treated cells were stained with Wright-Giemsa, and analysed by microscopy to allow the observation of granulocytic features (i.e. multilobular nucleus, prominent cellular indentation) as previously described (28) . 
Analysis of gene expression by RT-PCR
Total RNAs were extracted by using TRIZOL® reagent (Life Technologies) and 1 µg was reverse transcribed by using the reverse transcription system from Promega 
Invasion and migration assay
In vitro invasion was determined in the Matrigel-based assay as described previously by Janiack et al (34) . Briefly 
Enzyme-linked immunosorbent assay (ELISA)
Following indicated treatment, the MMP-9, TIMP-1 and TIMP-2 proteins levels were quantified by ELISA (Biotrak, Amersham-Bioscience, Orsay, France) in conditioned media from 10 5 cells, according to the manufacturer's instructions.
Statistics
Results from at least three independent experiments were given as mean ± SD, and oneway ANOVA with Student-Newman-Keuls post-hoc comparison was used for statistical significance with p ≤ 0.01.
RESULTS
Inhibition of ACLA-induced differentiation by antioxidants
Previous studies have determined the optimal differentiating dose of ACLA in the 20 to 30 nM range (13, 28) . Here, we have used a 25 nM concentration of ACLA to induce an 
ACLA-induced MMP-9 expression was inhibited by antioxidants
Untreated HL-60 cells have been previously described to express mainly MMP-9
gelatinase activity (21, 36). Gelatin zymography analysis of cell culture supernatants indicated that proMMP-9 secretion was strongly increased by ACLA treatment and inhibited in the hal-00422906, version 1 -8 Oct 2009
presence of NAC and PDTC (Fig. 3A) . Nevertheless, the inhibition of ACLA-induced proMMP-9 secretion was lower with PDTC than with NAC. This can be explained by the fact that PDTC alone increase the proMMP-9 secretion in control cells (Fig. 3A) . The ROSmediated increase of proMMP-9 in ACLA-treated cells, and the inhibitory effect of antioxidants, were confirmed by the quantification of proMMP-9 in cell culture supernatants by ELISA assay (Table I) . Furthermore, the appearance of active MMP-9 could be observed in whole cell lysates from ACLA-treated cells, and was inhibited in the presence of antioxidant (Fig. 3B) . At the mRNA level, MMP-9 gene expression was enhanced in the presence of ACLA, and NAC and PDTC acted as inhibitors of the ACLA transcriptional effect (Fig. 4 ). As observed with gelatin zymography, PDTC alone act as a weak stimulator of MMP-9 gene expression (Fig. 4) .
Effect of ACLA and NAC on TIMP-1 and TIMP-2 expression and secretion
TIMPs are the physiological inhibitors of MMPs activity and their expression and/or secretion is thought to be coordinated with MMPs control. TIMP-1 and TIMP-2 levels were therefore determined by ELISA assay in cell culture supernatants. The results indicated that TIMP-1 secretion was increased in ACLA-treated cells with respect to control cells and strongly decreased in the presence of NAC together with ACLA (Table II) . By contrast, TIMP-2 level was not significantly affected by ACLA-treatment (Table II) . In addition, RT-PCR analysis showed that TIMP-1 mRNA expression was up regulated in ACLA-treated cells, whereas TIMP-2 mRNA level remained unchanged (Fig. 4) . The antioxidants, NAC and PDTC, inhibited the effect of ACLA on TIMP-1 mRNA level, and were without effect on TIMP-2 mRNA level (Fig. 4) .
Cell migration and invasiveness were increased by ACLA treatment
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The above results suggest that ACLA is a modulator of the migration and/or invasion capacity of HL-60 cells. We have used transwell filters recovered, or not, by a Matrigel® layer to evaluate cell invasion or migration, respectively. As shown in Fig. 5A , an average of 3% of control HL-60 cells were able to cross the Matrigel® layer and the filter, this percentage was increased to 26% for ACLA-treated cells. The co-treatment with NAC slightly reduced the percentage of invasive cells to 21% (p<0.05, Fig. 5A ), suggesting the involvement of MMP-9, the expression of which was ROS-dependent. Furthermore, cell migration (i.e. in the absence of Matrigel®), which is independent of matrix degrading enzymes, was increased by ACLA treatment, but was unaffected in the presence of NAC (Fig.   5B ).
DISCUSSION
Differentiation of leukemia cells has prompted increasing research interest as an
alternative or support to conventional cytotoxic chemotherapy (37, 38) . In addition to the well documented effect of ATRA (39, 40) , some other molecules, including ACLA (7, 8) and butyric acid (38, 41) , appear as potential differentiating agents. In particular, ACLA induces differentiation of K562 and HL-60 human leukemia cell lines (8, 12, 13) . Nevertheless, the molecular mechanisms by which ACLA induces differentiation of leukemia cells are poorly understood. In the K562 cell line, a model of erythroid differentiation, we have previously demonstrated that ACLA act at the transcriptional level by increasing specific transcription factor synthesis and DNA-binding (8, 42) . Furthermore our recent results suggested the involvement of oxidative stress in the ACLA-triggered differentiation of K562 leukemic cells (27) . In these studies, subtoxic concentrations of ACLA were used to induce the erythroid differentiation of the human K562 cell line, and antioxidants were shown to inhibit the ACLA
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effect (27) . Here we have used the human HL-60 cell line to confirm the involvement of ROS production in the mechanism of action of ACLA in an other differentiation model. The clear inhibition of ACLA-induced HL-60 differentiation by antioxidant indicates that the ACLAtriggered ROS production is sufficient to engage most of the cells in the granulocytic differentiation pathway. However, the reason why only 75% of cell differentiate, and why the granulocytic pathway rather than the monocytic one is stimulated remain to be elucidated. 
